Significance of an novel germline AR mutation in black men with prostate cancer
患有前列腺癌的黑人男性中一种新的种系 AR 突变的意义
基本信息
- 批准号:8367933
- 负责人:
- 金额:$ 11.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-02 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAfrican AmericanAgeAgonistAllelesAndrogen AntagonistsAndrogen ReceptorAndrogen Response ElementAndrogensArchivesBase SequenceBenignBindingBiologic CharacteristicBiologicalBiological AssayCancer PatientCaucasiansCaucasoid RaceCell LineCell modelCellsCharacteristicsCodon NucleotidesDNA BindingDNA Binding DomainDataDetectionDevelopmentDiagnosisDiagnosticEpithelial CellsEthnic OriginFamilyFrequenciesFunctional disorderFutureGene ExpressionGene TargetingGenerationsGenesGeneticGenetic PolymorphismGenomicsGenotypeGrowthHealthHormonesIn VitroIncidenceIndividualInheritedLaboratoriesLengthLigandsLinkage DisequilibriumMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of prostateMethodsMissense MutationMolecularMutationNeoplasmsNuclearOligonucleotidesPatientsPatternPhenotypePopulationPopulation Attributable RisksPositioning AttributePredispositionProstateProstate-Specific AntigenRaceRecording of previous eventsRelative (related person)Reporter GenesResearchResearch PersonnelRiskRisk AssessmentRisk FactorsRoleSignal TransductionSingle Nucleotide PolymorphismSite-Directed MutagenesisStagingSusceptibility GeneSystemTestingTimeTissuesTransactivationTransfectionVariantbasecancer cellcell typecohortcombinatorialdeprivationdesigndisorder riskethnic differencegenome wide association studyhigh riskinterestmalemembermenmortalitymutantnovelpromoterprostate carcinogenesisprotein expressionracial differencereceptorreceptor expressionresponserestriction enzymesteroid hormonetumor progression
项目摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulators of gene expression as biomarkers for prostate cancer.
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:5.3
- 作者:S. Willard;S. Koochekpour
- 通讯作者:S. Willard;S. Koochekpour
Androgen receptor mutations and polymorphisms in African American prostate cancer.
- DOI:10.7150/ijbs.8974
- 发表时间:2014
- 期刊:
- 影响因子:9.2
- 作者:Koochekpour S;Buckles E;Shourideh M;Hu S;Chandra D;Zabaleta J;Attwood K
- 通讯作者:Attwood K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAHRIAR KOOCHEKPOUR其他文献
SHAHRIAR KOOCHEKPOUR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAHRIAR KOOCHEKPOUR', 18)}}的其他基金
Therapeutic Efficacy of Riluzole in Prostate Cancer
利鲁唑治疗前列腺癌的疗效
- 批准号:
8751365 - 财政年份:2014
- 资助金额:
$ 11.52万 - 项目类别:
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
非裔美国人前列腺癌中的代谢型谷氨酸受体 1
- 批准号:
8675361 - 财政年份:2014
- 资助金额:
$ 11.52万 - 项目类别:
Therapeutic Efficacy of Riluzole in Prostate Cancer
利鲁唑治疗前列腺癌的疗效
- 批准号:
8889227 - 财政年份:2014
- 资助金额:
$ 11.52万 - 项目类别:
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
非裔美国人前列腺癌中的代谢型谷氨酸受体 1
- 批准号:
8829801 - 财政年份:2014
- 资助金额:
$ 11.52万 - 项目类别:
PROSAPOSIN, A NOVEL INFLAMMATORY RESPONSE FACTOR FOR PROSTATE CANCER PROGRESSION
PROSAPOSIN,一种前列腺癌进展的新型炎症反应因子
- 批准号:
8360448 - 财政年份:2011
- 资助金额:
$ 11.52万 - 项目类别:
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
- 批准号:
8147010 - 财政年份:2010
- 资助金额:
$ 11.52万 - 项目类别:
Prognostic value of AR mutation in primary African American prostate cancer
AR 突变在非裔美国人原发性前列腺癌中的预后价值
- 批准号:
8416144 - 财政年份:2010
- 资助金额:
$ 11.52万 - 项目类别:
Prognostic value of AR mutation in primary African American prostate cancer
AR 突变在非裔美国人原发性前列腺癌中的预后价值
- 批准号:
7989304 - 财政年份:2010
- 资助金额:
$ 11.52万 - 项目类别:
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
- 批准号:
8391445 - 财政年份:2010
- 资助金额:
$ 11.52万 - 项目类别:
Prosaposin: A Novel Biomarker of Prostate Cancer Progression in African Americans
Prosaposin:非裔美国人前列腺癌进展的新型生物标志物
- 批准号:
8501024 - 财政年份:2010
- 资助金额:
$ 11.52万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 11.52万 - 项目类别:
Continuing Grant














{{item.name}}会员




